晨光生物(300138.SZ)業績快報:2022年度淨利同比增長23.94% 主導產品辣椒紅銷量首破9000噸
格隆匯2月28日丨晨光生物(300138.SZ)披露2022年度業績快報,報吿期內,公司實現營業收入62.96億元,同比增長29.18%;歸屬於上市公司股東的淨利潤4.36億元,同比增長23.94%;扣除非經常性損益後的歸屬於上市公司股東的淨利潤3.73億元,同比增長30.91%。
公司主導產品辣椒紅銷量首次突破9000噸,領先優勢進一步擴大;辣椒精產品搶抓時機快速收購高性價比的印度辣椒,競爭優勢顯著提升;葉黃素產品穩中求進,銷量繼續保持行業領先;營養藥用類產品延續良好發展勢頭,食品級葉黃素銷量增長約20%以上;番茄紅素產品緊密圍繞客户需求,拓寬應用範圍,銷量創歷史新高;迷迭香提取物銷售收入1200多萬元,同比增長80%;水飛薊素銷售收入3600多萬元,同比實現翻番;甜菊糖產品在優化工藝、精細管理的基礎上,與國內外多個大客户建立穩定的合作關係,全年銷售收入突破2億元,行業影響力大幅提升;香辛料產品整體業務穩紮穩打,應用型產品陸續與國內高端客户達成合作;保健食品業務不斷拓展市場,銷售收入突破8000萬元,同比增長80%。
棉籽蛋白業務加強對行情的分析把控,依靠公司在行業內的優良信譽和品牌影響力,持續做好原料採購與產品銷售的對鎖經營,有效規避了行情波動帶來的風險,全年加工棉籽60多萬噸,同比增長37%,實現銷售收入35億元,同比增長50%以上。繼續加強原料基地建設,新疆、雲南、印度、贊比亞等地原料種植面積的穩定及增長,為公司長遠發展打下了基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.